Market Overview - On the first trading day of the Year of the Horse, Hong Kong's three major indices continued to decline, with the Hang Seng Technology Index dropping over 2% and the Hang Seng Index falling over 1% [1][6] - The Hang Seng Index closed at 26,431.18, down by 274.76 points or 1.03% [2][7] - The Hang Seng China Enterprises Index ended at 8,973.39, decreasing by 96.93 points or 1.07% [2][7] - The Hang Seng Technology Index finished at 5,247.78, down by 119.74 points or 2.23% [2][7] Company Performance - Baidu Group saw a significant decline, with its stock price dropping by 5.09% to 130.60 [4][7] - NetEase experienced a decrease of 4.43%, closing at 179.00 [4][7] - Alibaba's stock fell by 3.75%, ending at 148.90 [4][7] - Li Auto's shares dropped by 3.26%, closing at 69.75 [4][7] - Other notable declines included Bilibili, Xiaomi, and Sunny Optical Technology, all of which fell over 2% [1][6]

来源：新浪基金∞工作室 流动性方面，截止2月13日，港股互联网ETF博时（159568）近20个交易日累计成交金额18.56亿元，日 均成交金额9280.31万元；今年以来，30个交易日，累计成交金额35.85亿元，日均成交金额1.20亿元。 港股互联网ETF博时（159568）现任基金经理为李庆阳。李庆阳自2024年2月8日管理（或拟管理）该基 金，任职期内收益66.36%。 最新定期报告显示，港股互联网ETF博时（159568）重仓股包括腾讯控股、阿里巴巴-W、小米集团- W、美团-W、商汤-W、快手-W、贝壳-W、京东健康、哔哩哔哩-W、金蝶国际，持仓占比如下。 股票代码股票名称持仓占比持仓股数（股）持仓市值（元）00700腾讯控股15.35%12.02万6503.17万 09988阿里巴巴-W14.43%47.39万6112.35万01810小米集团-W13.96%166.64万5915.14万03690美团- W12.30%55.85万5210.95万00020商汤-W4.08%869.70万1728.17万01024快手-W3.77%27.65万1597.09万 02423贝壳-W3.73%42. ...

Core Insights - The automotive industry in Jiading is undergoing a significant transformation, with a focus on smart and connected vehicles, aiming to exceed a scale of 300 billion yuan by 2025 [2] - Jiading's integrated circuit industry is projected to achieve a total output of 105.8 billion yuan by 2025, reflecting a 3.8% year-on-year growth [3] - The biopharmaceutical sector is rapidly developing, with initiatives aimed at establishing Jiading as a leading hub for high-end medical devices and innovative therapies [8] Automotive Industry - Jiading's automotive sector is transitioning from testing and demonstration to large-scale commercial applications, with the Shanghai International Automobile City collaborating with 18 major car manufacturers to create a transparent supply chain management platform [2] - The government plans to accelerate the development of a world-class smart connected new energy vehicle innovation hub by 2026, with a focus on high-value and new energy models [2] - The evolution of vehicles into intelligent terminals is supported by advancements in high-performance automotive chips and solid-state battery production [2] Integrated Circuit Industry - Jiading is positioned as a key player in Shanghai's integrated circuit strategy, with a focus on domestic production capabilities and a complete industry chain [5] - The establishment of innovation centers and collaborative platforms is aimed at enhancing the local semiconductor manufacturing ecosystem [5] - The development of specialized companies, such as Liyang Chip, demonstrates the effectiveness of the regional industrial cluster strategy [3] Biopharmaceutical Industry - The biopharmaceutical sector is characterized by rapid growth, with significant projects like the establishment of high-end medical device clusters and innovative treatment centers [8] - Jiading aims to create a comprehensive ecosystem for precision medicine, integrating clinical research and application [8] - The collaboration with institutions like Ruijin Hospital and Fudan University is expected to foster advancements in biotechnologies and medical devices [8] Social and Cultural Development - Jiading's development strategy includes social initiatives such as the provision of affordable housing and community services, enhancing the quality of life for residents [10] - Cultural events like the Shanghai Auto Culture Festival are expected to boost tourism and local consumption [2][10] - The integration of industry and community development reflects Jiading's commitment to a balanced approach to urban growth [10]

Investment Rating - The report assigns a "Buy" rating for Alibaba Health, with a target price of HKD 7.39 per share [7]. Core Insights - The main business of Alibaba Health is experiencing accelerated growth, driven by the online penetration of innovative drugs and the integration of AI technologies, which present new opportunities for the company [7]. - The self-operated revenue of Alibaba Health has significantly increased, accounting for nearly 90% of total revenue, with a year-on-year growth of 19% to RMB 14.38 billion [7]. - The company is also the largest online B2C healthcare product retail platform in China, benefiting from deep collaboration with the Alibaba Group [7]. Summary by Sections Medical E-commerce Tracking - The online pharmacy market share is rapidly increasing, with innovative drugs driving growth. The retail pharmacy share has risen to 31.5%, while online pharmacies have reached 5.3% [14][15]. - The demand for original research drugs is increasing, with a shift towards online channels due to convenience and service [15][16]. Alibaba Health - The self-operated business is the main driver of revenue growth, with a 99% year-on-year increase in self-operated SKUs to 1.61 million [7]. - The company is enhancing its advertising capabilities, which will contribute significantly to profitability [7]. - AI technologies are expected to empower the main business, with initiatives like the "Qianwen Super Agent" and the medical AI assistant "Hydrogen Ion" app being developed [7]. Profit Forecast and Valuation - Revenue forecasts for fiscal years 2026 and 2027 are RMB 34.594 billion and RMB 38.235 billion, respectively, with adjusted net profits of RMB 2.499 billion and RMB 3.026 billion [2][7].

若此次上市顺利，京东产发将成为刘强东麾下第七家上市公司，紧随京东集团、京东健康、京东物流、 京东工业等步伐，完成京东系从电商零售到物流、工业再到基础设施的资本化闭环。这是继2025年12月 京东工业港股敲钟后，京东系短短一个月内迎来的又一IPO动作。 京东产发的逆袭 近期，港交所官网显示，京东集团旗下京东智能产发股份有限公司（下称"京东产发"）正式重启港股 IPO征程。美银证券、高盛、海通国际担任联席保荐人。 京东产发的基因，根植于刘强东2007年力排众议的自建物流决策。彼时电商行业盛行轻资产模式，而刘 强东坚持布局仓储物流基础设施，认为"物流是电商的生命线"。这一被当时市场质疑为"偏执"的选择， 最终孕育出京东产发的雏形——早期的集团基建部门，承担着京东物流网络的建设与运营职能。 支撑业绩增长的核心，是京东产发构建的"轻重资产融合"商业模式。传统物流地产行业以"买地-盖楼-收 租"的重资产模式为主，资金占用大、周转效率低，而京东产发通过三大业务板块的协同，破解了这一 行业痛点： 其一，基础设施解决方案业务作为核心支柱，2024年贡献收入31.6亿元，占比高达92.6%。值得注意的 是，该业务来自外部客户的收 ...

Group 1 - Major tech stocks in Hong Kong experienced a decline, with notable drops of approximately 4% for companies such as NetEase, Meituan, Bilibili, and Trip.com, while Baidu and Tencent fell over 3% [1][2] - The Hang Seng Index saw a broader market downturn, with a decline of 1% and the Hang Seng Tech Index dropping by 1.87% [2] - Specific stock performance included Kingdee International down by 4.98%, NetEase down by 4.15%, and Meituan down by 4.11%, among others [3]

2月12日，港股早盘震荡下挫，截至发稿，恒指跌幅扩大至1%，恒生科技指数跌1.87%。 | 名称 | 现价 | 涨跌 | 涨跌幅 | 成交额 | | --- | --- | --- | --- | --- | | 恒生指数 | 26985.33 | -281.05 | -1.03% | 1156亿 | | 恒生科技 | 5397.29 | -102.70 | -1.87% | 324亿 | | 恒生生物科技 | | 15889.51 - -163.37 - -1.02% | | 47亿 | | 恒生中国企业指数 | 9165.20 | -102.98 | -1.11% | 416亿 | | 恒生综合指数 | 4133.60 | -42.31 | -1.01% | 773亿 | | 名称 | 现价 | 涨跌 | 涨跌幅 ^ | | --- | --- | --- | --- | | 金蝶国际 | 11.070 | -0.580 | -4.98% | | 网易-S | 186.900 | -8.100 | -4.15% | | 美团-W | 85.200 | -3.650 | -4.11% | | 哔哩哔哩-W ...

Group 1 - AIA Group (81299), JD Health (86618), and JD Group (89618) have the highest short-selling ratios at 100.00% each [1][2] - Alibaba (09988), Tencent Holdings (00700), and Xiaomi Group (01810) lead in short-selling amounts, with HKD 1.557 billion, HKD 1.404 billion, and HKD 1.183 billion respectively [1][2] - Zhaojin Mining (01818), OSL Group (00863), and Prada (01913) have the highest deviation values at 44.29%, 35.21%, and 34.72% respectively [1][2] Group 2 - The top ten short-selling ratios include AIA Group (81299) at 100.00%, JD Health (86618) at 100.00%, and JD Group (89618) at 100.00% [2] - The top ten short-selling amounts show Alibaba (09988) leading with HKD 1.557 billion, followed by Tencent Holdings (00700) with HKD 1.404 billion [2] - The top ten deviation values highlight Zhaojin Mining (01818) with a deviation of 44.29%, indicating significant short-selling activity compared to its historical average [2][3]

2月11日，港股医药有所分化。创新药大面积回调，创新药纯度100%的港股通创新药ETF（520880）微 跌0.19%止步三连阳。医疗主题板块继续上行，港股通医疗ETF华宝（159137）走出四连涨，站上20日 均线。 | 分时 多日 1分 5分 15分 30分 · 给会屏 F9 后复农 超级盘加 面试 工具 @ (1) > | | 港般通医疗ETF华宝 | | 159137 | | --- | --- | --- | --- | --- | | 159137.SZ[桃投通四疗ETF华宜] 2026/02/11 歌 1.024 幅0.49%(0.005) 开 1.025 高 1.030 低 1.019 均回 | | | | | | MAS 1.0021 MA10 0.998 MA20 1.022 2026/01/12-2026/02/11(23日)▼ | | 0 | | +0.005 +0.499 | | | 1,160 | SZSE CNY 15:00:00 闭槽 | | T+0 / 0 | | 4-1,152 | | 净值走势 | | 华宝中证港股通医疗主题ETF | | | | DEF | -51.86 ...

Core Viewpoint - The BoShi Hong Kong Internet ETF (159568) has shown positive performance since its inception, with significant increases in both share count and fund size in 2025 [1][2]. Fund Performance - As of February 11, 2024, the BoShi Hong Kong Internet ETF closed with a gain of 0.78%, with a trading volume of 53.48 million yuan [1]. - The fund was established on February 8, 2024, with a management fee of 0.50% and a custody fee of 0.10% [1]. - The latest share count is 324 million, with a total fund size of 539 million yuan, reflecting a 27.57% increase in shares and a 27.24% increase in size since December 31, 2025 [1]. Liquidity Metrics - Over the last 20 trading days, the ETF has accumulated a trading volume of 2.066 billion yuan, averaging 103 million yuan per day [1]. - In the year to date, the ETF has seen a total trading volume of 3.446 billion yuan over 28 trading days, averaging 123 million yuan per day [1]. Fund Management - The current fund manager, Li Qingyang, has managed the ETF since its inception, achieving a return of 66.36% during his tenure [2]. - The ETF's top holdings include Tencent Holdings (15.35%), Alibaba-W (14.43%), Xiaomi Group-W (13.96%), and Meituan-W (12.30%), among others [2].